| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
356,804 | 322,540 | 292,894 | 411,423 | - | - | - | - | - | - | - |
Cost of goods sold | ||||||||||
267,991 | 256,367 | 231,415 | 294,290 | - | - | - | - | - | - | - |
Revenue | ||||||||||
- | - | - | - | 339,439 | 306,177 | 282,242 | 245,423 | 201,029 | 177,679 | 145,286 |
Cost of goods sold | ||||||||||
- | - | - | - | 240,358 | 235,059 | 217,069 | 184,163 | 150,944 | 123,373 | 106,833 |
Gross profit | ||||||||||
88,813 | 66,173 | 61,479 | 117,133 | 99,081 | 71,118 | 65,173 | 61,260 | 50,085 | 54,306 | 38,453 |
Operating expenses: | ||||||||||
Research and development | ||||||||||
57,634 | 53,818 | 58,287 | 57,376 | 44,533 | 45,959 | 45,853 | 38,288 | 30,855 | 20,962 | 16,545 |
Sales and marketing | ||||||||||
16,088 | 16,728 | 17,760 | 18,595 | 15,823 | 13,725 | 14,242 | 13,241 | 11,686 | 9,078 | 7,634 |
General and administrative | ||||||||||
29,759 | 30,403 | 34,453 | 34,409 | 31,635 | 31,570 | 30,012 | 24,361 | 20,911 | 16,628 | 14,673 |
Amortization of purchased intangible assets | ||||||||||
119 | 475 | 472 | 1,609 | 1,791 | 1,502 | 1,532 | 1,316 | 994 | 1,144 | 1,137 |
Asset sale related costs | ||||||||||
397 | 427 | 130 | - | - | - | - | - | - | - | - |
Acquisition and asset sale related costs | ||||||||||
- | - | - | 2,125 | 934 | 615 | 5,406 | 1,447 | 989 | - | - |
Goodwill impairment charges | ||||||||||
- | - | - | - | - | - | - | - | 13,106 | 0 | 0 |
Adjustment to fair value of contingent consideration | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 |
Restructuring charges | ||||||||||
261 | 3,135 | 3,934 | 0 | 44 | 662 | 775 | 68 | 1,297 | 0 | 0 |
Litigation settlement | ||||||||||
0 | -2,645 | 0 | 0 | - | - | - | - | - | - | - |
Loss (gain) on asset sale | ||||||||||
900 | -200 | 2,193 | 0 | 0 | - | - | - | - | - | - |
Asset impairment charges | ||||||||||
- | - | - | - | 368 | 1,130 | - | - | - | - | 1,233 |
Adjustment to fair value of contingent consideration | ||||||||||
- | - | - | - | - | - | 1,026 | -554 | -1,287 | - | - |
Escrow settlement gain | ||||||||||
- | - | - | - | - | 4,913 | - | - | - | - | - |
Total operating expenses | ||||||||||
103,355 | 107,831 | 112,843 | 114,114 | 95,128 | 90,250 | 98,846 | 78,167 | 78,551 | 47,812 | 41,222 |
Income (loss) from operations | ||||||||||
-14,542 | -41,658 | -51,364 | 3,019 | 3,953 | -19,132 | -33,673 | -16,907 | -28,466 | 6,494 | -2,769 |
Interest income | ||||||||||
376 | 397 | 198 | 303 | 121 | 189 | 348 | 592 | 407 | 187 | 340 |
Interest expense | ||||||||||
1,919 | 2,493 | 1,362 | 402 | 1,243 | 1,269 | 996 | 568 | 422 | 612 | 873 |
Other income (expense), net | ||||||||||
642 | 1,446 | 104 | 472 | 3,941 | 3,012 | 1,186 | 575 | 14,246 | -108 | -60 |
Total interest and other income (expense), net | ||||||||||
-901 | -650 | -1,060 | 373 | 2,819 | 1,932 | 538 | 599 | 14,231 | -533 | -593 |
Loss before income taxes | ||||||||||
-15,443 | -42,308 | -52,424 | 3,392 | 6,772 | -17,200 | -33,135 | -16,308 | -14,235 | 5,961 | -3,362 |
Income tax provision | ||||||||||
1,633 | 1,329 | 909 | 3,597 | 3,104 | 2,519 | 1,204 | 1,364 | 1,155 | -2,289 | 1,465 |
Loss from continuing operations | ||||||||||
- | - | - | - | - | - | - | -17,672 | -15,390 | 3,672 | -4,827 |
Income from discontinued operations, net of tax | ||||||||||
- | - | - | - | - | - | - | 142 | 636 | -401 | -2,020 |
Net income (loss) | ||||||||||
- | - | - | - | - | - | - | - | - | 3,271 | -6,847 |
Net income attributable to noncontrolling interests | ||||||||||
- | - | - | - | - | - | - | - | - | 80 | 116 |
Net income (loss) | ||||||||||
-17,076 | -43,637 | -53,333 | -205 | 3,668 | -19,719 | -34,339 | -17,530 | -14,754 | 3,191 | -6,963 |
Deemed dividend on beneficial conversion of Series X redeemable convertible preferred stock | ||||||||||
- | - | - | - | - | - | - | - | 17,049 | - | - |
Deemed dividend on beneficial conversion of Series X redeemable convertible preferred stock | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 |
Accretion of redeemable convertible preferred stock | ||||||||||
- | - | - | - | - | - | - | - | 7 | 113 | 153 |
Net loss attributable to NeoPhotonics Corporation common stockholders | ||||||||||
- | - | - | - | - | - | - | - | -31,810 | 3,078 | -7,116 |
Continuing operations | ||||||||||
- | - | - | - | - | - | - | - | - | 0.00 | -2.66 |
Discontinued operations | ||||||||||
- | - | - | - | - | - | - | - | - | 0.00 | -1.06 |
Basic net income (loss) per share (in dollars per share) | ||||||||||
- | - | - | 0.00 | 0.10 | -0.61 | -1.11 | - | - | 0.00 | -3.72 |
Continuing operations | ||||||||||
- | - | - | - | - | - | - | - | - | 0.00 | -2.66 |
Discontinued operations | ||||||||||
- | - | - | - | - | - | - | - | - | 0.00 | -1.06 |
Diluted net income (loss) per share (in dollars per share) | ||||||||||
- | - | - | 0.00 | 0.09 | -0.61 | -1.11 | - | - | 0.00 | -3.72 |
Weighted average shares used to compute basic net income (loss) per share (in shares) | ||||||||||
- | - | - | 41,798 | 37,421 | 32,109 | 31,000 | - | - | 1,945 | 1,913 |
Weighted average shares used to compute diluted net income (loss) per share (in shares) | ||||||||||
- | - | - | 41,798 | 38,686 | 32,109 | 31,000 | - | - | 3,123 | 1,913 |
Continuing operations | ||||||||||
- | - | - | - | - | - | - | - | -1.45 | - | - |
Discontinued operations | ||||||||||
- | - | - | - | - | - | - | - | 0.03 | - | - |
Basic and diluted net loss per share (USD per share) | ||||||||||
-0.36 | -0.97 | -1.23 | - | - | - | - | -0.62 | -1.42 | - | - |
Weighted average shares used to compute basic and diluted net loss per share (in shares) | ||||||||||
47,304 | 45,144 | 43,431 | - | - | - | - | 28,530 | 22,359 | - | - |